Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state

Summary

The bill expands the state’s newborn screening list to include CLN2, MPS IVA, MPS VI, MPS VII, and Fabry disease. It directs the health commissioner to make tests for these conditions available within twelve months of the law’s effective date. Early detection is intended to improve outcomes for affected infants and families.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share